Eflapegrastim-Xnst
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Safety and efficacy of same-day administration of eflapegrastim in patients with early-stage breast cancer receiving chemotherapy.
Journal: The oncologist
Published: April 15, 2025
Ryzneuta for prevention of febrile neutropenia.
Journal: The Medical letter on drugs and therapeutics
Published: August 13, 2024
Eflapegrastim (Rolvedon) for prevention of chemotherapy-induced febrile neutropenia.
Journal: The Medical letter on drugs and therapeutics
Published: May 22, 2023
Eflapegrastim-xnst.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: January 23, 2023
Showing 1-4 of 4
Last Updated: 06/30/2026